Dana Investment Advisors’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.31M Buy
131,829
+36,016
+38% +$1.3M 0.11% 217
2026
Q1
$3.39M Buy
95,813
+7,880
+9% +$321K 0.1% 231
2025
Q4
$3.57M Buy
87,933
+25,325
+40% +$1.1M 0.1% 216
2025
Q3
$2.94M Buy
62,608
+11,655
+23% +$604K 0.09% 239
2025
Q2
$2.65M Buy
50,953
+5,290
+12% +$290K 0.09% 245
2025
Q1
$2.76M Buy
+45,663
New +$2.94M 0.1% 231
2022
Q4
Sell
-17,271
Closed -$1.39M 404
2022
Q3
$1.39M Buy
17,271
+4,253
+33% +$401K 0.08% 165
2022
Q2
$1.25M Buy
13,018
+385
+3% +$46.2K 0.06% 203
2022
Q1
$1.88M Sell
12,633
-1,166
-8% -$163K 0.09% 136
2021
Q4
$1.96M Sell
13,799
-777
-5% -$110K 0.08% 140
2021
Q3
$1.91M Buy
14,576
+9,919
+213% +$1.3M 0.09% 136
2021
Q2
$640K Sell
4,657
-648
-12% -$88.7K 0.03% 235
2021
Q1
$693K Buy
5,305
+318
+6% +$38.3K 0.03% 232
2020
Q4
$559K Buy
4,987
+2,406
+93% +$228K 0.03% 233
2020
Q3
$203K Buy
+2,581
New +$210K 0.01% 276
2020
Q1
Sell
-18,963
Closed -$2.12M 281
2019
Q4
$2.12M Sell
18,963
-4,769
-20% -$508K 0.1% 124
2019
Q3
$2.28M Sell
23,732
-595
-2% -$55.9K 0.12% 119
2019
Q2
$2.08M Buy
+24,327
New +$2M 0.1% 140

Other funds holding CNMD

Dana Investment Advisors's CNMD Position: Q2 2026 in Review

Dana Investment Advisors increased its CONMED (CNMD) stake by 38% in Q2 2026, buying an estimated $1.3M and bringing the position to 131,829 shares worth $4.31M. The position accounts for 0.11% of the portfolio, ranked #217.

Dana Investment Advisors first reported a position in CNMD in Q2 2019 and has held it in 18 quarters since. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • Dana Investment Advisors held 131,829 shares of CONMED worth $4.31M as of Q2 2026.
  • Dana Investment Advisors bought 36,016 CONMED shares in Q2 2026, an estimated $1.3M.
  • CONMED made up 0.11% of Dana Investment Advisors's portfolio in Q2 2026, its #217 holding.
  • Dana Investment Advisors first reported a position in CONMED in Q2 2019 and has held it in 18 quarters since.
  • 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Dana Investment Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.